e-Drug3D

763

cas 118292-40-3

CLASS

DERMATOLOGIC AGENTS
KERATOLYTIC AGENTS
PRODRUGS
TERATOGENS
RETINOIDS
TREATMENT OF PSORIASIS AND ACNE
RAPIDLY HYDROLYSED IN TAZAROTENIC ACID

ROUTE (list)

TOPICAL

PK parameters

t1/2 6 HOUR

MW 351.46
NB_atoms 25
XLogP 4.43
PSA 36.007
NB_HD 0
NB_HA 3
fsp3 0.33
Lipinski(0=no;1=yes) 1

FDA
NDA 020600 (pdf not found) INN (TAZAROTENE) TAZORAC (ALLERGAN) APPROVAL= AP YEAR= 1997 NEWMOLECULARENTITY
NDA 021184 (pdf not found) INN (TAZAROTENE) TAZORAC (ALLERGAN) APPROVAL= AP YEAR= 2000
NDA 202428 (pdf not found) INN (TAZAROTENE) FABIOR (MAYNE PHARMA) APPROVAL= AP YEAR= 2012
NDA 208258 (pdf not found) INN (TAZAROTENE) TAZAROTENE (TARO) APPROVAL= AP YEAR= 2017
NDA 208662 (pdf not found) INN (TAZAROTENE) TAZAROTENE (COSETTE) APPROVAL= AP YEAR= 2017
NDA 209354 (pdf not found) INN (HALOBETASOL PROPIONATE ; TAZAROTENE) DUOBRII (BAUSCH) APPROVAL= AP YEAR= 2019
NDA 211175 (pdf not found) INN (TAZAROTENE) TAZAROTENE (FOUGERA PHARMS INC) APPROVAL= AP YEAR= 2019 DISCONTINUED
NDA 211882 (pdf not found) INN (TAZAROTENE) ARAZLO (BAUSCH) APPROVAL= AP YEAR= 2019
NDA 214136 (pdf not found) INN (TAZAROTENE) TAZAROTENE (COSETTE) APPROVAL= AP YEAR= 2022
NDA 215433 (pdf not found) INN (TAZAROTENE) TAZAROTENE (COSETTE) APPROVAL= AP YEAR= 2022
NDA 213079 (pdf not found) INN (TAZAROTENE) TAZAROTENE (PADAGIS ISRAEL) APPROVAL= AP YEAR= 2023
NDA 213644 (pdf not found) INN (TAZAROTENE) TAZAROTENE (SOLARIS PHARMA CORP) APPROVAL= AP YEAR= 2023
NDA 217190 (pdf not found) INN (HALOBETASOL PROPIONATE ; TAZAROTENE) HALOBETASOL PROPIONATE; TAZAROTENE (TARO PHARMS) APPROVAL= TA YEAR= 2023
NDA 217075 (pdf not found) INN (TAZAROTENE) TAZAROTENE (PADAGIS ISRAEL) APPROVAL= AP YEAR= 2024
NDA 215393 (pdf not found) INN (TAZAROTENE) TAZAROTENE (PADAGIS ISRAEL) APPROVAL= AP YEAR= 2025